Alexander Taub

Today we officially kick off our $2M pre seed round for Salubrum (Backed by Forum Ventures), supported by Forum Ventures, Coeus Collective Ventures, and Draper House Americas. Healthcare companies spend over $30B a year trying to acquire patients. The problem is not media. The problem is timing. Every time a patient approaches a healthcare decision a moment opens. Which doctor to see. Which procedure to pursue. Which treatment to start. For the companies involved in that decision, knowing that moment exists is incredibly valuable. Salubrum (Backed by Forum Ventures) is building the intelligence layer that maps those decision moments across the U.S. patient population. Our system aggregates large healthcare datasets covering 300M+ patient identities and uses them to predict when individuals are approaching important healthcare decisions. That signal can then be used by providers, pharma companies, payers, and other healthcare organizations trying to reach patients at the right time. Our first wedge is patient acquisition for healthcare providers and brands, but the underlying intelligence layer has much broader applications wherever patient behavior influences economic decisions. Over the past months we have quietly built the foundation. • Early pilots validating our patient intent scoring system • Distribution partnerships forming across healthcare platforms • Backed by Forum Ventures, Coeus Collective Ventures, Draper House Americas, NEXT Canada and Metta World Peace Starting tomorrow we will be meeting investors as part of the Forum Ventures showcase. If you are an investor interested in building with us get in touch. Calendly: https://lnkd.in/e5j-VvGC Investor Memo: https://lnkd.in/e5HyemAp

95

6 Comments

Today Isembard announced a $50m Series A fundraise led by Union Square Ventures, less than a year after Notion Capital led their Seed round. 💥This is a company right at the intersection of AI & supply chain sovereignty & they’re exceeding even our most optimistic expectations. By the end of the year they will have 25 factories across the UK, US, Germany, France & Ukraine. 💥Isembard is rapidly scaling its network of AI-first factories for precision manufacturing at the same time as market demand is accelerating. Macro forces (reshoring, rising defence spend, concentration risk in Asia, and the growth of neo-primes) are structurally increasing demand for fast, local, flexible manufacturing that the current industry is unable to deliver on. 💥The innovation is in the way the company builds and franchises factories as a product with tightly integrated units of machines, software, robotics, & process intelligence that turn design files into certified components with speed & reliability. 💥Their AI software platform, MasonOS, connects all sites into a single operating system, replacing fragmented shops with standardised, high-performance industrial nodes & enabling real-time quoting, predictable delivery, & low defect rates. By owning the full production stack, Isembard delivers premium manufacturing performance with the scalability & flexibility of a software platform. 💥We are at the top of the AI hype cycle and there are understandable concerns about the ROI on the vast sums of money being invested into this new super-cycle. But, the ROI for Isembard is both clear and compelling. They will deliver components 10x faster and at 50% of the cost of current suppliers. They will also build a de-centralised, global network of factories to meet the growing demand for national or regional sovereignty. 💥This is a company with a clear vision to disrupt a massive, fragmented $1.8tn component manufacturing market. Today marks another huge stride towards that vision. And they are only just getting started. We’re thrilled to be on this journey with Alexander Fitzgerald & the team & we’re also excited to welcome Rebecca Kaden & USV into the investor base. Notion Capital Union Square Ventures Alexander Fitzgerald Rebecca Kaden Maximilian Eichler Stephen Millard Britt Mulder

56

6 Comments

I’m thrilled to officially announce our $3M seed investment in Propel People, a company we built inside the 1848 Ventures studio to tackle one of the biggest challenges facing the #construction industry today: the skilled #labor shortage. For small and medium-sized contractors, hiring isn't just a challenge. It's the number one threat to their growth, profitability, and safety. With 94% of contractors struggling to find qualified workers, it’s clear that traditional hiring methods aren't built for the trades. That’s why we built Propel People. It’s a mobile-first, AI-powered hiring platform designed for how construction actually works: in the field. By leveraging smart candidate ranking, instant #SMS-based screening, and a fully #bilingual interface, Propel helps contractors build great crews faster and more efficiently. I’m also thrilled to formally announce that industry veteran Dexter Bachelder is at the helm as CEO. Having worked with Dexter and the team over the last few months, we've already seen the impact of his leadership. His 25 years of experience scaling construction tech companies will be instrumental as Propel People enters this initial stage of growth. This investment reinforces our core thesis at 1848 Ventures: building AI-native companies that solve fundamental pain points for the #SMBs that form the backbone of our economy. A huge congratulations to Dexter and the entire Propel People team on this milestone. We are incredibly proud to partner with you to support the people who build our world. Read the full announcement below. #constructiontech #venturecapital #seedfunding #ai #skilledtrades #smb

144

14 Comments

Every #VentureStudio GP knows some portfolio bets won’t hit. That's expected - and it's one of the reasons studios are such a powerful vehicle for innovation. And while a venture's failure might be what's visible to the outsider, what keeps them up at night isn’t failure at the venture level — it’s failure at the systemic level within the studio. One bad entity design. One IP misstep. One governance gap. That’s how studio operations fall apart. We break down how to spot (and fix) these cracks before they turn into fault lines in our latest paper, "The GP Dilemma" - DM me and I'll send you a copy!

4

I’ve known David Meister for years and backed him at Sydecar, so I’ve seen his ability to build through complexity. Axiom Trust is taking on one of the most outdated parts of wealth infrastructure, trust administration, by pairing a regulated trust company with AI-native workflows. We're proud to invest again and congrats to the team on the launch!

18

1 Comment

Check out the latest funding news from across the Techstars portfolio. → Zipline (Techstars 2011), a drone delivery and logistics startup, raises more than $600M in new funding, boosting its valuation to $7.6B, as it expands commercial deployments. → Language learning startup Preply (Techstars 2015) raises $150M and becomes the 23rd known unicorn from Techstars accelerators. → Hydrosat (Techstars 2019) raises $60M in Series B funding → Tive (Techstars 2017) receives a $20M investment, valuing the shipment-tracking systems developer at slightly more than $500M. → Parambil (Techstars 2023) raises an additional $6M in seed funding ($8M to date). → Seasats (Techstars 2021) receives $24M in Department of War APFIT funding to accelerate the fielding of its autonomous surface vessels. → Hawaiian Airlines’ newly announced $600M Kahuʻewai Hawai‘i Investment Plan features a strategic investment in Ampaire (Techstars 2018) to support hybrid-electric aviation in the islands. → Fintalo (Techstars 2025) secures $500K+ in oversubscribed Pre-Seed funding. → PraxisPro (Techstars 2024) closes an oversubscribed $6M seed round. → Samara Aerospace (Techstars 2024) closes $10M seed round to help bring more stability to sats in orbit. → MyARC (Techstars 2022), a platform that enables fitness creators to train their communities at scale, secures £1.5M investment. Massive congratulations to these incredible portfolio companies!   🔗  Read more at https://lnkd.in/dxtCTvrg 

164

7 Comments

At Vibe Capital, we believe the venture landscape is bifurcating. The reason is simple: reality is full of drunk cats. "Drunk Cats" are the emergent, second-order effects that arise from simple rules. They can tank a product, entire system, or an entire country. The ability to see -and master - these drunk cats reveals the true split in startups today. It is no longer between software and hardware, but between "impressionistic" founders who map the world as it is, and "mechanistic" founders who can reverse-engineer reality from first principles. My latest Dave's Quick Hits newsletter provides the playbook for identifying and funding these mechanistic architects. It is about a fundamental shift from describing effects to mastering cause. I break down the three core stages of the Mechanistic Playbook: 1. See the System: Identifying the hidden rules and emergent flaws in any complex system, from software to biology. 2. Debug the System: Using technology to patch the legacy "bugs" of a previous industrial paradigm. 3. Architect a New System: Building with true primitives, like DNA, to program matter itself. The next trillion-dollar companies won't be built by operators chasing surface-level trends. They'll be built by system-thinkers who can see, debug, and architect reality’s source code. You can read the full analysis and the investment theses here: https://lnkd.in/dkhkBUwh #VentureCapital #DeepTech #FrontierTech #Investing #Strategy #Biotechnology #Nanotechnology #vibecap #vibecapital #drunkcats

13

I’m thrilled to announce defy.vc’s investment in Birches Health as part of their $20M combined Seed and Series A funding round, alongside incredible partners like AlleyCorp, General Catalyst, Will Ventures, and others. As someone deeply passionate about backing companies that tackle important problems for our society, I couldn’t be more excited about what Birches is building—a national virtual clinic dedicated to treating gambling addiction and related behavioral disorders like gaming, sex, porn, and internet addictions. What excites me most is Birches’ innovative health assurance model: proactive, accessible, and affordable care that’s evidence-based and delivered right at home. With the explosion of legal sports betting—think nearly $1.5 billion wagered on this year’s Super Bowl alone—we’re staring down a looming public health emergency. Traditional options like hotlines or generic therapy fall short for this high-acuity issue, but Birches changes that by offering specialized therapy from trained clinicians, multimodal treatment, and peer support, all covered by major insurers like United Healthcare, Cigna, Aetna, and Blue Cross Blue Shield. It’s available in all 50 states, breaking down geographical and financial barriers that have left so many without help. The impact is already profound: 96% of patients report an improved quality of life, and 94% give Birches a 5/5 rating. By partnering with state governments, payors, and policymakers, Birches is pushing gambling addiction into the spotlight of behavioral health conversations, where it’s been neglected for too long—often leading to shame, worsened outcomes, and higher suicidality risks. This funding will supercharge their growth: expanding the provider network, boosting clinical excellence, scaling infrastructure, and deepening insurance and state partnerships to meet surging demand. Very excited to partner with Elliott Rapaport and the entire Birches team! See more about our POV in the blog post linked in the comments. #GamblingAddiction #BehavioralHealth #HealthTech #VentureCapital #Innovation

159

10 Comments